Area of research
Dermatology · Surgery
Research interest
Research interests include Hidradenitis Suppurativa and Treatments, Colorectal and Anal Carcinomas, Chemotherapy-related skin toxicity, and Acne and Rosacea Treatments and Effects.
Prevalence of Hidradenitis Suppurativa
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis
Hidradenitis suppurativa pathogenesis: Extrinsic factors
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations
Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice
PCR225 Predictors of Health-Related Quality of Life across Rare Diseases: An Online Survey
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
Hidradenitis Suppurativa in the Pediatric Population
Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States
Dermatology COVID-19 Registries
Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy
Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum
Characterizing perimenstrual flares of hidradenitis suppurativa
Comprehensive approach to managing hidradenitis suppurativa patients
Diagnosis and management of hidradenitis suppurativa in women
Retrospective cohort study of pregnancy outcomes in hidradenitis suppurativa
Remote management of hidradenitis suppurativa in a pandemic era of COVID‐19
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Skin Microbiota Perturbations Are Distinct and Disease Severity–Dependent in Hidradenitis Suppurativa
Distribution of Self-reported Hidradenitis Suppurativa Age at Onset
The TNFRSF members CD27 and OX40 coordinately limit T <sub>H</sub> 17 differentiation in regulatory T cells
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (<scp>SHSA</scp>) 2017